The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Berenberg downgrades Biffa, raises Kosmos

Thu, 25th Aug 2022 09:42

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

Investec cuts Aveva to 'hold' ('buy') - target 2,700 pence

----------

Jefferies raises Centrica price target to 90 (72) pence - 'hold'

----------

JPMorgan raises Rentokil Initial price target to 650 (600) pence - 'overweight'

----------

FTSE 250

----------

UBS raises FirstGroup price target to 120 (114) pence - 'neutral'

----------

Liberum raises Centamin price target to 121 (102) pence - 'buy'

----------

Berenberg cuts Marshalls price target to 400 (620) pence - 'hold'

----------

Berenberg cuts Biffa to 'hold' ('buy') - target 415 (465) pence

----------

Jefferies cuts Coats price target to 96 (100) pence - 'buy'

----------

SMALL CAP

----------

RBC starts Digital 9 Infrastructure with 'outperform' - price target 145 pence

----------

Jefferies cuts Severfield price target to 101 (108) pence - 'buy'

----------

Berenberg raises Kosmos Energy to 'buy' ('hold') - target 710 (670) pence

----------

Liberum starts coverage on Open Orphan at 'buy' - 21.6p price target

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 Nov 2019 16:29

Open Orphan inks preferred partner deal with Ipsen Group

(Sharecast News) - Europe-focussed rare and orphan drug consulting services platform Open Orphan announced the signing of a preferred partner agreement with Ipsen Group on Monday.

Read more
11 Nov 2019 13:48

Open Orphan Inks Venn Life Preferred Partner Agreement With Ipsen

Open Orphan Inks Venn Life Preferred Partner Agreement With Ipsen

Read more
15 Oct 2019 13:11

Open Orphan Inks Health Data Platform Deal With Empiric Logic

Open Orphan Inks Health Data Platform Deal With Empiric Logic

Read more
15 Oct 2019 11:13

Open Orphan signs deal with Empiric Logic to complete Health Data platform

(Sharecast News) - Europe-focussed rare and orphan drug consulting services platform provider Open Orphan has signed a new strategic collaboration agreement with Empiric Logic, it announced on Tuesday, to build on the earlier work it had performed, and complete the build out of its 'Health Data' platform as Europe's first rare disease, advocacy-led genomic database.

Read more
25 Sep 2019 11:51

Open Orphan Loss Widens On Venn Life Sciences Combination Cost

Open Orphan Loss Widens On Venn Life Sciences Combination Cost

Read more
1 Aug 2019 17:37

Open Orphan Names Ex-Horizon Therapeutics Director As Non-Executive

(Alliance News) - Drug consulting platform Open Orphan PLC said on Thursday that it has appointed David Kelly as an independent non-executive director.Kelly, the company said, has orphan in

Read more
12 Jul 2019 11:57

Open Orphan Divests Remaining 3.1% Stake In Integumen

(Alliance News) - Open Orphan PLC has netted over GBP500,000 after selling the rest of its shares in skin-care firm Integumen PLC, Open Orphan said on Friday.The sale of the 30.1 million on

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.